Jiangsu Hengrui Medicine is a manufacturer and supplier of antineoplastics and surgical medicines for the healthcare industry... Read more
Jiangsu Hengrui Medicine is a manufacturer and supplier of antineoplastics and surgical medicines for the healthcare industry... Read more
Annual Revenue
$3.7B
Employees
24,000
News
Oct 30, 2023
Saltwire
Jiangsu Hengrui Pharmaceutical: Merck KGaA widens work on 'DNA damage' drugs in deal with China's Hengrui | SaltWire
Aug 15, 2023
Yicai Global
Jiangsu Hengrui Pharmaceutical: China's Hengrui Pharma Licenses New Asthma Drug to US' One Bio for Up to USD1 Billion
May 18, 2022
ChinaBio Today
Jiangsu Hengrui Pharmaceutical: Hengrui Launches Luzsana to Bring its Novel Medications to Global Markets
Dec 31, 2021
Equal Ocean
Jiangsu Hengrui Pharmaceutical: Hengrui pharmaceutical sglt-2 inhibitor hengglijing was approved in China
Nov 21, 2021
Markets Insider
Jiangsu Hengrui Pharmaceutical: CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China
Aug 26, 2021
Benzinga
Jiangsu Hengrui Pharmaceutical: BeyondSpring Inks Plinabulin Agreement In Greater China
Feb 10, 2021
ChinaBio Today
Jiangsu Hengrui Pharmaceutical: Hengrui Acquires PI3k Inhibitor Rights from Shanghai Lingli Pharma
Feb 09, 2021
StreetInsider
Press Release: Jiangsu Hengrui Pharmaceutical : Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China
Oct 21, 2020
EIN Presswire
Press Release: Jiangsu Hengrui Pharmaceutical : China Focus Conference Facilitates Collaboration Between Dyadic and Jiangsu Hengrui Medicine for COVID-19 Vaccine
Sep 17, 2020
Business News Asia
Jiangsu Hengrui Pharmaceutical: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
Jiangsu Hengrui Pharmaceutical Competitors
1
2
3
4
5
6
7
8
9
10